Prognostic Significance of the Cyto-Histological Classification of Infiltrating Cervical Epidermoid Carcinoma

1980 ◽  
Vol 66 (2) ◽  
pp. 183-190 ◽  
Author(s):  
Paolo Dalla Palma ◽  
Carla Arslan Pagnini ◽  
Giuseppe de Laurentiis
Keyword(s):  
Cell Carcinoma ◽  
Classification System ◽  
Survival Rates ◽  
Prognostic Significance ◽  
Large Cell Carcinoma ◽  
Large Cell ◽  
Small Cell ◽  
Histological Classification ◽  
Cervical Carcinomas

One hundred-fifty-five cervical carcinomas were classified according to the Wentz and Reagan (21) cyto-histological system, and correlated to 5 year survival rates. This classification subdivides epidermoid carcinomas into three sub-groups: keratinizing carcinoma, large cell carcinoma, and small cell carcinoma. No significant differences between one group and another were observed. The importance of the type of therapy in conditioning the significance of this classification system is discussed.

scholarly journals Das anaplastische Lungenkarzinom des Hundes

1973 ◽  
Vol 10 (2) ◽  
pp. 102-113 ◽  
Author(s):  
H. Stünzi
Keyword(s):  
Cell Carcinoma ◽  
Large Cell Carcinoma ◽  
Large Cell ◽  
Domestic Animals ◽  
Small Cell ◽  
Round Cell ◽  
Histological Criteria ◽  
Pulmonary Tumors ◽  
Pulmonary Neoplasia

Of 86 canine pulmonary tumors five had the histological criteria of undifferentiated small-cell carcinoma and two of undifferentiated large-cell carcinoma. The five small-cell anaplastic careinomas could be divided, as is the case in man, according to strict histological criteria into fusiform, lymphocyte-like, and polygonal subgroups. In the fusiform and round-cell subgroups there were focal sites of equivocal differentiation towards epidermoid careinoma or adenocarcinoma. These local changes must be considered in making a diagnosis, but it was not possible to positively determine the behavior of anaplastic, epidermoid or glandular carcinomas. The classification of pulmonary carcinomas of domestic animals has significance not only for experimental oncology but also for clarification of the cause of pulmonary neoplasia. Anaplastic pulmonary carcinomas have not been found in the cat.

scholarly journals A case of small cell carcinoma of the lung differentiated toward large cell carcinoma and adenocarcinoma during treatment.

1991 ◽  
Vol 30 (3) ◽  
pp. 507-511
Author(s):  
Hitoshi HIRATA ◽  
Yutaka MIZUSHIMA ◽  
Saburo YANO ◽  
Mikio KITASAWA ◽  
Ken FUKUMURA ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Large Cell Carcinoma ◽  
Large Cell ◽  
Small Cell

Histological Typing of Lung Tumours

1981 ◽  
Vol 67 (4) ◽  
pp. 253-272 ◽  
Author(s):  
◽  
E. Chaves ◽  
Toão Pessoa ◽  
O. Campobasso ◽  
J. Chrétien ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Large Cell Carcinoma ◽  
Large Cell ◽  
Intermediate Cell ◽  
Cell Type ◽  
Histological Differentiation ◽  
Lung Tumours ◽  
Oat Cell Carcinoma

The WHO Histological Classification of Lung Tumours, published in 1967, has been revised. The main features are as follows: Squamous cell carcinoma (epidermoid carcinoma) has the same definition as in the original version, i.e., the identification of keratin and/or intercellular bridges by light microscopy. Three degrees of histological differentiation are described. Dysplasia and carcinoma in situ are discussed. Small cell carcinoma is divided into oat-cell carcinoma, an intermediate cell type and a category for oat-cell carcinomas combined with other major types. Adenocarcinoma includes the acinar, papillary and bronchiolo-alveolar forms and the solid carcinomas with mucus formation (previously part of the large cell carcinoma group). Mesothelial tumours are divided into fibrous, epithelial and biphasic subtypes. A number of less common tumours and tumour-like lesions are defined.

scholarly journals Rare Occurrence of a Poorly Differentiated Neuroendocrine Tumor of the Bladder

2017 ◽  
Vol 2017 ◽  
pp. 1-4 ◽  
Author(s):  
Katherine Dowd ◽  
Charles Rotenberry ◽  
Douglas Russell ◽  
Mitchell Wachtel ◽  
Werner de Riese
Keyword(s):  
Cell Carcinoma ◽  
Neuroendocrine Tumor ◽  
Survival Data ◽  
Large Cell Carcinoma ◽  
Large Cell ◽  
Disease Recurrence ◽  
Small Cell ◽  
Treatment Regimens ◽  
Poorly Differentiated ◽  
Carcinoma Of The Bladder

Neuroendocrine tumors rarely occur in the urinary bladder. They can be carcinomatous, subdivided into small cell and large cell pathology. Small cell carcinoma of the bladder is a rarity that may present at an advanced pathologic stage. No treatment regimens have been standardized for local or metastatic disease. Review of the recent literature shows equivalent survival data for localized disease treated with chemoradiotherapy combined with either bladder sparing surgery or radical cystectomy. Patients with significant comorbidities are an additional challenge. We report a case of poorly differentiated neuroendocrine tumor of the bladder, which could not be classified as small or large cell carcinoma, complicated by significant comorbidities. After management with transurethral resection of the tumor, adjuvant chemotherapy, and radiation, the patient is alive and asymptomatic nearly 1 year after initial TURBT with no evidence of disease recurrence.

Neuro-endocrine tumours of the head and neck

1990 ◽  
Vol 104 (6) ◽  
pp. 504-507 ◽  
Author(s):  
A. C. Soussi ◽  
A. Benghiat ◽  
C. S. Holgate ◽  
B. Majumdar
Keyword(s):  
Cell Carcinoma ◽  
Head And Neck ◽  
Small Cell Carcinoma ◽  
Neuroendocrine Carcinoma ◽  
Large Cell Carcinoma ◽  
Large Cell ◽  
Differential Response ◽  
Small Cell ◽  
Endocrine Tumours ◽  
Carcinoma Of The Larynx

AbstractWe report two types of neuroendocrine carcinoma of the head and neck, small cell carcinoma of the ethmoid and large cell carcinoma of the larynx, demonstrating a differential response to radiotherapy.

Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.

1985 ◽  
Vol 3 (11) ◽  
pp. 1478-1485 ◽  
Author(s):  
D Osoba ◽  
J J Rusthoven ◽  
K A Turnbull ◽  
W K Evans ◽  
F A Shepherd
Keyword(s):  
Lung Cancer ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Performance Status ◽  
Large Cell Carcinoma ◽  
Large Cell ◽  
Small Cell ◽  
Entire Group ◽  
Small Cell Lung

Fifty-three patients with recurrent and advanced stage (III and IV) non-small-cell lung cancer (NSCLC) were treated with a combination of bleomycin, etoposide (VP-16-213), and cis-diamminedichloroplatinum (BEP). Forty-eight patients were appraisable for response. The response rates were 44% for the entire group, 57% in 30 patients with combined squamous-cell and large-cell carcinoma, and 22% in 18 patients with adenocarcinoma (40%, 50%, and 19%, respectively, if patients not appraisable for response are included as nonresponders). The median survival time of patients with squamous-cell and large-cell carcinoma was slightly longer than that of patients with adenocarcinoma (23 weeks v 19 weeks). Patients with responsive disease survived significantly longer (median, 34 weeks) than did patients with unresponsive disease (median, 16 weeks) (P = .001). In the entire group, the median survival time of patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 was better (23 weeks) than of those with a status of 2 or 3 (15 weeks), but this difference was not seen in the subgroup with squamous-cell and large-cell carcinoma (24 weeks v 23 weeks, respectively). Thus, the performance status was not of prognostic value in the histologic subgroups experiencing the best response rate. There were two treatment-related deaths, but otherwise the toxicity of BEP was acceptable. Only four of the 119 treatment cycles were followed by fever even though there was significant neutropenia (0.5 X 10(9)/L) after 20 of 97 treatment cycles. The majority of patients receiving BEP experienced relief of cough, hemoptysis, pain, and fatigue associated with their disease. There was a good correlation between objective responses and palliation of symptoms. Thus, BEP offers good palliation, particularly for patients with squamous-cell and large-cell lung cancer.

Sign in / Sign up

Export Citation Format

Share Document